Analystreport

Millendo Therapeutics Inc (NASDAQ: MLND) is now covered by analysts at CIBC. They set an "outperform" rating and a $26.00 price target on the stock.

Millendo Therapeutics, Inc. - Common Stock  (MLND) 
Last millendo therapeutics, inc. - common stock earnings: 11/13 08:30 am Check Earnings Report